132 related articles for article (PubMed ID: 23485791)
1. Guillain-Barré syndrome after H1N1 influenza: a concern.
Wiwanitkit V
Neuroepidemiology; 2013; 40(4):295. PubMed ID: 23485791
[No Abstract] [Full Text] [Related]
2. Guillain-Barré syndrome after H1N1 vaccination in the United States: a report using the CDC/FDA Vaccine Adverse Event Reporting System (2009).
Souayah N; Yacoub HA; Khan HM; Michas-Martin PA; Menkes DL; Maybodi L; Qureshi AI
Neuroepidemiology; 2012; 38(4):227-32. PubMed ID: 22555646
[TBL] [Abstract][Full Text] [Related]
3. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome.
Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E
Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755
[TBL] [Abstract][Full Text] [Related]
4. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010.
Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR
Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165
[TBL] [Abstract][Full Text] [Related]
5. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition.
Choe YJ; Cho H; Bae GR; Lee JK
Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684
[TBL] [Abstract][Full Text] [Related]
6. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis.
Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N;
Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095
[TBL] [Abstract][Full Text] [Related]
7. Are the atypical forms of Guillain-Barré syndrome correlated with H1N1-influenza vaccination?
Li S; Zhu J
Vaccine; 2012 Aug; 30(38):5585. PubMed ID: 22728223
[No Abstract] [Full Text] [Related]
8. Atypical forms of Guillain-Barré syndrome and H1N1-influenza vaccination.
Shaikh AG; Termsarasab P; Nwankwo C; Rao-Frisch A; Katirji B
Vaccine; 2012 May; 30(22):3251-4. PubMed ID: 22429755
[TBL] [Abstract][Full Text] [Related]
9. Guillain-Barré syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database.
Alcalde-Cabero E; Almazán-Isla J; García López FJ; Ara-Callizo JR; Avellanal F; Casasnovas C; Cemillán C; Cuadrado JI; Duarte J; Fernández-Pérez MD; Fernández Ó; Merino JA; Montero RG; Montero D; Pardo J; Rodríguez-Rivera FJ; Ruiz-Tovar M; de Pedro-Cuesta J;
BMC Neurol; 2016 May; 16():75. PubMed ID: 27206524
[TBL] [Abstract][Full Text] [Related]
10. Guillain-Barré syndrome and H1N1 influenza vaccine in UK children.
Verity C; Stellitano L; Winstone AM; Andrews N; Stowe J; Miller E
Lancet; 2011 Oct; 378(9802):1545-6. PubMed ID: 22035553
[No Abstract] [Full Text] [Related]
11. H1N1 vaccine safety monitoring: beyond background rates.
Destefano F; Tokars J
Lancet; 2010 Apr; 375(9721):1146-7. PubMed ID: 19880171
[No Abstract] [Full Text] [Related]
12. International collaboration to assess the risk of Guillain Barré Syndrome following Influenza A (H1N1) 2009 monovalent vaccines.
Dodd CN; Romio SA; Black S; Vellozzi C; Andrews N; Sturkenboom M; Zuber P; Hua W; Bonhoeffer J; Buttery J; Crawford N; Deceuninck G; de Vries C; De Wals P; Gutierrez-Gimeno MV; Heijbel H; Hughes H; Hur K; Hviid A; Kelman J; Kilpi T; Chuang SK; Macartney K; Rett M; Lopez-Callada VR; Salmon D; Gimenez-Sanchez F; Sanz N; Silverman B; Storsaeter J; Thirugnanam U; van der Maas N; Yih K; Zhang T; Izurieta H;
Vaccine; 2013 Sep; 31(40):4448-58. PubMed ID: 23770307
[TBL] [Abstract][Full Text] [Related]
13. [Guillain-Barré syndrome secondary to H1N1 influenza vaccine].
López Nieto M; Gómez Garrido J; Losa Palacios A; Aguila Manso G
Rev Clin Esp; 2010 Oct; 210(9):485-6. PubMed ID: 20832792
[No Abstract] [Full Text] [Related]
14. Guillain-Barré syndrome after influenza vaccination.
Wiwanitkit V
J Clin Neuromuscul Dis; 2013 Mar; 14(3):126. PubMed ID: 23492466
[No Abstract] [Full Text] [Related]
15. Did the influenza A (H1N1) 2009 monovalent inactivated vaccines increase the risk for Guillain-Barré syndrome?
Salmon DA; Vellozzi C; Chen RT; Halsey NA
Expert Rev Clin Immunol; 2013 Sep; 9(9):795-7. PubMed ID: 24070041
[No Abstract] [Full Text] [Related]
16. Guillain-Barré syndrome associated with H1N1 vaccination.
Marin LF; Abrahão A; Carvalho FA; Santos WA; Dallalba CC; Barcelos LB; Silva GS; Oliveira AS
Arq Neuropsiquiatr; 2010 Dec; 68(6):974-5. PubMed ID: 21243265
[No Abstract] [Full Text] [Related]
17. Hospital discharge data for Guillain-Barré syndrome and influenza A (H1N1) vaccine adverse events.
Jones TF; McMillian M; Boothe E; Hanna S; Ingram LA
Emerg Infect Dis; 2010 Sep; 16(9):1500-1. PubMed ID: 20735949
[No Abstract] [Full Text] [Related]
18. Influenza vaccine and Guillain-Barré syndrome: making informed decisions.
Poland GA; Poland CM; Howe CL
Lancet; 2013 Apr; 381(9876):1437-9. PubMed ID: 23622271
[No Abstract] [Full Text] [Related]
19. Pandemic vaccines and small excess of Guillain-Barre cases.
BMJ; 2013 Mar; 346():f1714. PubMed ID: 23516147
[No Abstract] [Full Text] [Related]
20. [Guillain-Barre syndrome and the mass vaccination against A/H1N1. No increase of the risk has been reported so far].
Press R; Andersen O
Lakartidningen; 2010 Mar 10-16; 107(10):666-7. PubMed ID: 20402249
[No Abstract] [Full Text] [Related]
[Next] [New Search]
